BRCA2 and breast cancer: In fact, 15 to 20% of all TNBC cases are linked with the germline mutations in BRCA1 or BRCA2 (13) and in US, 12% of breast cancers are contributed by TNBCs with a 5 year survival rate of 8 to 16 percent only (14).